USPTO serial 97133002
MCSTEM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 6, 2023
- Examiner
- HARMON, RAYMOND E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MCSTEM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Todd A. Denys
Todd A. Denys PORZIO, BROMBERG & NEWMAN, P.C.600 ALEXANDER ROAD, SUITE 2-1PRINCETON, NJ 08540UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for use in industry and science; Biological preparation for use in cell cultures other than for medical or veterinary use; Cultures of cell media for scientific and research use, other than for medical or veterinary use; Biological tissue cultures, other than for medical or veterinary purposes; Stem cells for research purposes; Stem cells for scientific purposes; Nutritive agents for processing living cells, other than for medical use; Media for cell culture for use in the biotechnical industry, other than for medical use; Media for cell culture for use in non-medical research laboratories | ACTIVE | — |
| 009 | Scientific apparatus for cell culture systems, namely, cytometers and biomimetic 3D culture systems composed of cell culture dishes for cell culture systems; Cultured cell scientific apparatus for scientific use for analysis and sorting of cells, namely, laboratory pipettes and capsules for the analysis and sorting of cell culture; Bioreactor for cell culturing; Cultured cell observing apparatus for laboratory use, namely cell culture dishes and tissue culture flaks ; Cell culture incubators; Cell culture apparatus for laboratory use, namely, namely cell culture dishes and tissue culture flaks; cell filtration apparatus for laboratory use; cell sorting apparatus for laboratory use; micro fluidics chips being microfluidic chips for droplet and particle generation for laboratory use; downloadable software used for the collection, analysis, sorting, and communication of biological information relating to stem cells | ACTIVE | — |
| 010 | Apparatus for the regeneration of stem cells for use in the diagnosis and treatment of Parkinson's disease, neurodegenerative diseases, heart disease, diabetes, Non-Alcoholic Steatohepatitis, acute liver failure, Age-related macular degeneration, limbal stem cells deficiencies, traumatic injury, skin burns, spinal cord injuries, huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases; Apparatus for culture cell systems for medical use, namely, cell culture chambers and capsules for use in the diagnosis and treatment of Parkinson's disease, neurodegenerative diseases, heart disease, diabetes, Non-Alcoholic Steatohepatitis, acute liver failure, Age-related macular degeneration, limbal stem cells deficiencies, traumatic injury, skin burns, spinal cord injuries, huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases; Apparatus for encapsulation of culture cell systems for use in the diagnosis and treatment of Parkinson's disease, neurodegenerative diseases, heart disease, diabetes, Non-Alcoholic Steatohepatitis, acute liver failure, Age-related macular degeneration, limbal stem cells deficiencies, traumatic injury, skin burns, spinal cord injuries, huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases; Cell culture apparatus for analysis and sorting of cells for use in the diagnosis and treatment of Parkinson's disease, neurodegenerative diseases, heart disease, diabetes, Non-Alcoholic Steatohepatitis, acute liver failure, Age-related macular degeneration, limbal stem cells deficiencies, traumatic injury, skin burns, spinal cord injuries, huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases; cell filtration apparatus for use in the diagnosis and treatment of Parkinson's disease, neurodegenerative diseases, heart disease, diabetes, Non-Alcoholic Steatohepatitis, acute liver failure, Age-related macular degeneration, limbal stem cells deficiencies, traumatic injury, skin burns, spinal cord injuries, huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases; cell sorting apparatus for {use in the diagnosis and treatment of Parkinson's disease, neurodegenerative diseases, heart disease, diabetes, Non-Alcoholic Steatohepatitis, acute liver failure, Age-related macular degeneration, limbal stem cells deficiencies, traumatic injury, skin burns, spinal cord injuries, huntington disease, amyotrophic lateral sclerosis, Alzheimer's disease, stroke, burns, cancer, osteoarthritis, Multiple Sclerosis, Radiation Induced Intestinal Injury, Inflammatory Bowel Disease, Liver Disease, Duchenne Muscular Dystrophy, Bone Disease, Renal Disease, Chronic Wounds, Graft-Versus-Host Disease, Sepsis and Respiratory diseases | ACTIVE | — |
| 041 | Publishing and issuing of scientific papers in the in the field of biotechnology and medical technology; Publication of the results of clinical trials; Publication of scientific information journals; Publishing and issuing scientific papers in relation to biotechnology | ACTIVE | — |
| 042 | Laboratory research in the field of biotechnology; scientific research on stem cells; scientific research on the production of pluripotent stem cells by encapsulation; research and development in the field of stem cells, cell and gene therapy and biotechnology; pharmaceutical research and development; scientific laboratory services; providing information with respect to scientific research in the field of stem cells, cell and gene therapy and biotechnology; scientific research on the production of differentiated cells by encapsulation; scientific research in the field of laboratory apparatus, medical apparatus, educational apparatus and simulators; scientific research in the field of cell analysis, cell sorting and cell filtration | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TREEFROG THERAPEUTICS
- Other trademarks owned by TREEFROG THERAPEUTICS
- Other trademarks owned by TREEFROG THERAPEUTICS
- Other trademarks in Class 001
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named MCSTEM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 6, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 6, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 21, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 21, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 1, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 14, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 14, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 14, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 14, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 14, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 26, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 26, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 26, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jul 26, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 13, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jul 8, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jul 7, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jul 1, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jun 27, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 24, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 24, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 24, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 7, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 7, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 7, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 23, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 22, 2021 | NWAP | NEW APPLICATION ENTERED | — |